Clinic Built Around a Medication People Take Every Month | 100% Subscription-Based

I have built a highly profitable subscription-based telehealth clinic, centered entirely around GLP-1 weight loss medications that patients receive on a recurring monthly basis. This is not a discretionary or trend-based service. The clinic provides the compounded semaglutide, tirzepatide, and adjunct weight-loss protocols that patients take month after month, refill after refill, year after year.

The trailing twelve month financials speak for themselves. My clinic has generated revenue of $547,290 with a net profit of $164,847 on a trailing twelve month basis.

What makes this clinic particularly attractive is the revenue model. The overwhelming majority of my sales come through automatic monthly refill subscriptions. That means patients are not consulting once and moving on. They are enrolled in a recurring monthly medication delivery program and continuing the same protocol on autopilot.

I do not spend heavily on advertising to chase new patients because I do not need to. GLP-1 medications have become one of the most searched health categories in the country, and patients actively seek out compliant telehealth clinics that can provide continuous monthly access. My multi-state licensed provider network handles the consultations, my 503A compounding pharmacy partner handles all fulfillment and direct-to-patient shipping, and the subscription refills simply keep coming in.

The service catalog covers the full range of medically supervised weight loss protocols: compounded semaglutide, compounded tirzepatide, oral semaglutide, adjunct weight-loss support medications, and provider consultation and follow-up care. These are prescription protocols that patients continue on for six to eighteen months at a time. That cycle is what drives the subscription base and what gives this business its stability.

I am selling because I have identified a real estate investment opportunity and want to redeploy the equity I have built in this business into that acquisition. This business is performing well and I am not selling due to any problems with the clinic, the provider network, the pharmacy partner, or the revenue.

Important Notes:

1.) Trailing twelve month revenue of $547,290 and net profit of $164,847
2.) Majority of revenue generated through automatic monthly refill subscriptions, creating recurring predictable cash flow
3.) Minimal paid advertising required. Nationwide patient demand for GLP-1 medications drives organic inquiries and provider reputation drives retention
4.) Fully remote and home-based operation. Multi-state licensed provider network handles consultations and 503A compounding pharmacy handles all shipping
5.) Established LegitScript certification (active and transferable) — a regulatory asset that new entrants cannot quickly replicate
6.) Simple and scalable operation with no employees required. Contract providers and pharmacy partners handle all fulfillment
7.) Established recurring patient subscription base that renews automatically without additional marketing intervention
8.) Ideal acquisition for a buyer looking for stable, recurring revenue in the fastest-growing segment of healthcare